Copyright
©The Author(s) 2015.
World J Gastroenterol. Oct 28, 2015; 21(40): 11282-11303
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11282
Published online Oct 28, 2015. doi: 10.3748/wjg.v21.i40.11282
Table 7 Treatment with herbal remedies
Author | n | Producto | Comparador | Indicación | Remisión/response herbal vs PB or drug (%) |
Langmead | 44 | Aloe vera | Placebo | Induction remission CU | 30 vs 7 |
Ben-Arye | 23 | Triticum aestivum | Placebo | Induction remission CU | 91 vs 42 |
Khan | 14 | Bovine colostrum enema | Placebo | Induction remission CU | |
Sandborn | 224 | HMPL-004 | Placebo | Induction remission CU | 38/60 vs 25/40 |
Fukunaga | 30 | Xilei-san suppository | Placebo | Induction remission CU | 46 vs 0 |
Zhang | 35 | XIlei-san enema | Enema dexametasona | Induction remission CU | |
Tang | 120 | HMPL-004 | Mesalazina | Induction remission CU | 21 vs 16 |
Gupta | 30 | Boswellia serrata | Sulfasalazina | Induction remission CU | 70 vs 40 |
Cheng | 153 | Jian Pi Ling tablet | Sulfasalazina | Induction remission CU | 53 vs 28/19 |
Placebo | |||||
Wang | 106 | Kui Jie Quing enemas | Sulfasalazina | Induction remission CU | 72 vs 9 |
Prednisolona | |||||
Cheng | 118 | Yukui tang ablets | Prednisolonoa | Induction remission CU | 33 vs 17 |
Neomicina | |||||
Vitamina B | |||||
Fernández Bañares | 105 | Plantago ovata sedes | Mesalazine | Maintenance remission CU | 60 vs 65 |
Hanai | 89 | Curcumin | Placebo | Maintenance remission CU | 95 vs 79 |
Greenfield | 43 | Oenothera biennis | Evening primrose oil and olive oil | Maintenance remission CU | |
Omer | 40 | Artemisia absinthium | Placebo | Treatment and prevention recurrence EC | 65 vs 0 |
Krebs | 20 | Artemisia absinthium | Placebo | Treatment and prevention recurrence EC | 80 vs 20 |
Gerhardt | 102 | Boswellia serrata extract | Mesalazine | Treatment and prevention recurrence EC | 36 vs 31 |
Ren | 20 | Tripterygium wilfordii | Placebo | Treatment and prevention recurrence EC | |
Holtmeier | 108 | Boswellia serrata extract | Placebo | Treatment and prevention recurrence EC | 60 vs 55 |
Tao | 45 | Tripterygium wilfordii | Mesalazine | Treatment and prevention recurrence EC | 68 vs 61 |
Liao | 39 | Tripterygium wilfordii | Sulphasalazine | Treatment and prevention recurrence EC | 94 vs 75 |
- Citation: Gómez-Gómez GJ, Masedo &, Yela C, Martínez-Montiel MDP, Casís B. Current stage in inflammatory bowel disease: What is next? World J Gastroenterol 2015; 21(40): 11282-11303
- URL: https://www.wjgnet.com/1007-9327/full/v21/i40/11282.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i40.11282